Dolofab SP Tablet

Dolofab SP Tablet is a combination of three medicines: Aceclofenac, Paracetamol/Acetaminophen and Serratiopeptidase. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID), and Paracetamol/Acetaminophen is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation and promotes healing.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dolofab SP Tablet is to be taken with food.

Alcohol Unsafe

It is unsafe to consume alcohol with Dolofab SP Tablet .

Pregnancy Unsafe

Dolofab SP Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

Breastfeeding Ask your doctor

No information is available on the use of Dolofab SP Tablet during lactation. Please consult your doctor.

Driving Caution

Dolofab SP Tablet may make you feel dizzy, drowsy or affect your vision. Do not drive until your vision is clear.

Kidney Caution

Dolofab SP Tablet should be used with caution in patients with kidney disease. Dose adjustment of Dolofab SP Tablet may be needed. Please consult your doctor. Use of Dolofab SP Tablet is not recommended in patients with severe kidney disease.

Liver Caution

Dolofab SP Tablet should be used with caution in patients with liver disease. Dose adjustment of Dolofab SP Tablet may be needed. Please consult your doctor. However, the use of Dolofab SP Tablet is not recommended in patients with severe liver disease and active liver disease.